| Carbapenems: past, present, and future KM Papp-Wallace, A Endimiani, MA Taracila, RA Bonomo Antimicrobial agents and chemotherapy 55 (11), 4943-4960, 2011 | 1792 | 2011 |
| New β-lactamase inhibitors: a therapeutic renaissance in an MDR world SM Drawz, KM Papp-Wallace, RA Bonomo Antimicrobial agents and chemotherapy 58 (4), 1835-1846, 2014 | 346 | 2014 |
| Manganese transport and the role of manganese in virulence KM Papp-Wallace, ME Maguire Annu. Rev. Microbiol. 60, 187-209, 2006 | 302 | 2006 |
| Can ceftazidime-avibactam and aztreonam overcome β-lactam resistance conferred by metallo-β-lactamases in Enterobacteriaceae? S Marshall, AM Hujer, LJ Rojas, KM Papp-Wallace, RM Humphries, ... Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02243-16, 2017 | 269 | 2017 |
| Inhibitor resistance in the KPC-2 β-lactamase, a preeminent property of this class A β-lactamase KM Papp-Wallace, CR Bethel, AM Distler, C Kasuboski, M Taracila, ... Antimicrobial agents and chemotherapy 54 (2), 890-897, 2010 | 220 | 2010 |
| New β-lactamase inhibitors in the clinic KM Papp-Wallace, RA Bonomo Infectious Disease Clinics 30 (2), 441-464, 2016 | 185 | 2016 |
| Treatment options for infections caused by carbapenem-resistant Enterobacteriaceae: can we apply “precision medicine” to antimicrobial chemotherapy? F Perez, NG El Chakhtoura, KM Papp-Wallace, BM Wilson, RA Bonomo Expert opinion on pharmacotherapy 17 (6), 761-781, 2016 | 180 | 2016 |
| Prevalence and antibiotic resistance patterns of diarrheagenic Escherichia coli isolated from adolescents and adults in Hamedan, Western Iran MY Alikhani, SH Hashemi, MM Aslani, S Farajnia Iranian journal of microbiology 5 (1), 42, 2013 | 158* | 2013 |
| Unexpected challenges in treating multidrug-resistant Gram-negative bacteria: resistance to ceftazidime-avibactam in archived isolates of Pseudomonas aeruginosa ML Winkler, KM Papp-Wallace, AM Hujer, TN Domitrovic, KM Hujer, ... Antimicrobial agents and chemotherapy 59 (2), 1020-1029, 2015 | 144 | 2015 |
| Strategic approaches to overcome resistance against Gram-negative pathogens using β-lactamase inhibitors and β-lactam enhancers: activity of three novel diazabicyclooctanes WCK … KM Papp-Wallace, NQ Nguyen, MR Jacobs, CR Bethel, MD Barnes, ... Journal of medicinal chemistry 61 (9), 4067-4086, 2018 | 127 | 2018 |
| WCK 5107 (zidebactam) and WCK 5153 are novel inhibitors of PBP2 showing potent “β-lactam enhancer” activity against Pseudomonas aeruginosa, including multidrug-resistant … B Moya, IM Barcelo, S Bhagwat, M Patel, G Bou, KM Papp-Wallace, ... Antimicrobial agents and chemotherapy 61 (6), 10.1128/aac. 02529-16, 2017 | 119 | 2017 |
| Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loop ML Winkler, KM Papp-Wallace, RA Bonomo Journal of antimicrobial chemotherapy 70 (8), 2279-2286, 2015 | 119 | 2015 |
| Non-phenotypic tests to detect and characterize antibiotic resistance mechanisms in Enterobacteriaceae A Lupo, KM Papp-Wallace, P Sendi, RA Bonomo, A Endimiani Diagnostic microbiology and infectious disease 77 (3), 179-194, 2013 | 116 | 2013 |
| The latest advances in β-lactam/β-lactamase inhibitor combinations for the treatment of Gram-negative bacterial infections KM Papp-Wallace Expert opinion on pharmacotherapy 20 (17), 2169-2184, 2019 | 113 | 2019 |
| Novel β-lactamase inhibitors: a therapeutic hope against the scourge of multidrug resistance RR Watkins, KM Papp-Wallace, SM Drawz, RA Bonomo Frontiers in microbiology 4, 392, 2013 | 107 | 2013 |
| Variants of β-lactamase KPC-2 that are resistant to inhibition by avibactam KM Papp-Wallace, ML Winkler, MA Taracila, RA Bonomo Antimicrobial agents and chemotherapy 59 (7), 3710-3717, 2015 | 103 | 2015 |
| Molecular investigations of PenA-mediated β-lactam resistance in Burkholderia pseudomallei DA Rholl, KM Papp-Wallace, AP Tomaras, ML Vasil, RA Bonomo, ... Frontiers in microbiology 2, 11561, 2011 | 101 | 2011 |
| Klebsiella pneumoniae Carbapenemase-2 (KPC-2), Substitutions at Ambler Position Asp179, and Resistance to Ceftazidime-Avibactam: Unique Antibiotic … MD Barnes, ML Winkler, MA Taracila, MG Page, E Desarbre, ... MBio 8 (5), 10.1128/mbio. 00528-17, 2017 | 97 | 2017 |
| Resistance to novel β-lactam–β-lactamase inhibitor combinations: the “price of progress” KM Papp-Wallace, AR Mack, MA Taracila, RA Bonomo Infectious Disease Clinics 34 (4), 773-819, 2020 | 92 | 2020 |
| Avibactam and inhibitor-resistant SHV β-lactamases ML Winkler, KM Papp-Wallace, MA Taracila, RA Bonomo Antimicrobial agents and chemotherapy 59 (7), 3700-3709, 2015 | 89 | 2015 |
